Ameren (NYSE:AEE - Free Report) had its target price hoisted by BMO Capital Markets from $106.00 to $108.00 in a research note released on Monday morning,Benzinga reports. The brokerage currently has an outperform rating on the utilities provider's stock.
A number of other research firms have also commented on AEE. Evercore ISI upgraded Ameren from an "in-line" rating to an "outperform" rating and raised their price objective for the stock from $89.00 to $104.00 in a research note on Tuesday, January 21st. Morgan Stanley reiterated an "outperform" rating on shares of Ameren in a research note on Wednesday, April 23rd. Barclays dropped their target price on shares of Ameren from $102.00 to $101.00 and set an "equal weight" rating for the company in a research report on Tuesday, April 8th. Guggenheim reiterated a "neutral" rating on shares of Ameren in a research report on Tuesday, April 22nd. Finally, UBS Group boosted their price objective on shares of Ameren from $106.00 to $113.00 and gave the company a "buy" rating in a research report on Friday, March 21st. Four analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $99.89.
Check Out Our Latest Stock Analysis on AEE
Ameren Stock Performance
Shares of NYSE AEE traded down $1.89 during trading hours on Monday, reaching $97.66. 2,312,836 shares of the stock were exchanged, compared to its average volume of 1,582,933. The firm has a market capitalization of $26.36 billion, a price-to-earnings ratio of 22.09, a P/E/G ratio of 2.97 and a beta of 0.51. The stock's fifty day simple moving average is $98.60 and its 200 day simple moving average is $94.41. The company has a debt-to-equity ratio of 1.41, a quick ratio of 0.44 and a current ratio of 0.66. Ameren has a 52 week low of $69.39 and a 52 week high of $104.10.
Ameren (NYSE:AEE - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The utilities provider reported $1.07 earnings per share for the quarter, missing the consensus estimate of $1.08 by ($0.01). The firm had revenue of $2.10 billion for the quarter, compared to the consensus estimate of $1.92 billion. Ameren had a return on equity of 10.34% and a net margin of 15.51%. The firm's quarterly revenue was up 15.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.98 EPS. Sell-side analysts predict that Ameren will post 4.93 EPS for the current year.
Ameren Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Tuesday, March 11th were given a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a yield of 2.91%. The ex-dividend date was Tuesday, March 11th. This is an increase from Ameren's previous quarterly dividend of $0.67. Ameren's dividend payout ratio is currently 62.97%.
Insider Transactions at Ameren
In other news, insider Shawn E. Schukar sold 4,743 shares of the business's stock in a transaction dated Tuesday, March 4th. The stock was sold at an average price of $103.79, for a total value of $492,275.97. Following the transaction, the insider now directly owns 57,486 shares of the company's stock, valued at $5,966,471.94. The trade was a 7.62 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Craig S. Ivey sold 2,716 shares of Ameren stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $98.27, for a total value of $266,901.32. Following the completion of the sale, the director now owns 14,495 shares of the company's stock, valued at approximately $1,424,423.65. The trade was a 15.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 12,959 shares of company stock worth $1,316,712. Company insiders own 0.42% of the company's stock.
Institutional Trading of Ameren
Large investors have recently modified their holdings of the stock. Synergy Investment Management LLC acquired a new stake in Ameren in the fourth quarter worth $25,000. MJT & Associates Financial Advisory Group Inc. acquired a new stake in shares of Ameren in the 1st quarter valued at about $25,000. Roxbury Financial LLC bought a new stake in Ameren in the 4th quarter valued at about $27,000. Quarry LP acquired a new position in Ameren during the 4th quarter worth approximately $31,000. Finally, ORG Partners LLC boosted its holdings in Ameren by 74.5% in the first quarter. ORG Partners LLC now owns 349 shares of the utilities provider's stock worth $35,000 after acquiring an additional 149 shares in the last quarter. Institutional investors and hedge funds own 79.09% of the company's stock.
Ameren Company Profile
(
Get Free Report)
Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States. The company operates through four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. It engages in the rate-regulated electric generation, transmission, and distribution activities; and rate-regulated natural gas distribution business.
See Also

Before you consider Ameren, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ameren wasn't on the list.
While Ameren currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.